LONDON--(BUSINESS WIRE)--MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that it has been selected by Health Data Research UK (HDR UK) – the national institute for ...
Thirty-three female patients undergoing elective breast cancer surgery used MMS. The median age was 58 years. Nineteen patients underwent lumpectomy, and 14 underwent mastectomy. Users logged on to ...
CANTON, Mich.--(BUSINESS WIRE)--MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the launch of its pro-bono support program aimed at advancing research for ultra-rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback